A / A / A

neglected diseases

Antirétroviraux
Article

Deadly Gaps Persist in New Drug Development for Neglected Diseases

The Drugs for Neglected Diseases initiative (DNDi) and other researchers, including MSF-Crash Dr. Jean Hervé Bradol, report a persistent deficiency in truly new therapeutics for neglected diseases, despite nominal progress and an acceleration in research and development (R&D) efforts.